a public good project by the
Synthesis
Company
of California

© 2026

John C. LaRosa | doi.page

0 works0 citations0 h-index

John C. LaRosa

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Health Systems, Economic Evaluations, Quality of Life, Cancer, Lipids, and Metabolism, Estrogen and related hormone effects

Most-Cited Works

→ Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease(2005)3,486 cited
→ HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events(2007)1,611 cited
→ Effect of Statins on Risk of Coronary Disease(1999)1,253 cited
→ Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins(2012)789 cited
→ Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials(2019)772 cited
→ A specific apoprotein activator for lipoprotein lipase(1970)662 cited
→

Primary Prevention of Coronary Heart Disease: Guidance From Framingham

(1998)

613 cited

→ Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial(1995)605 cited

→ Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events(2014)579 cited

→ The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.(1990)560 cited